Related references
Note: Only part of the references are listed.Antigen-presenting genes and genomic copy number variations in the Tasmanian devil MHC
Yuanyuan Cheng et al.
BMC GENOMICS (2012)
Genome Sequencing and Analysis of the Tasmanian Devil and Its Transmissible Cancer
Elizabeth P. Murchison et al.
CELL (2012)
New Insights into the Role of MHC Diversity in Devil Facial Tumour Disease
Amanda Lane et al.
PLOS ONE (2012)
Genomic Restructuring in the Tasmanian Devil Facial Tumour: Chromosome Painting and Gene Mapping Provide Clues to Evolution of a Transmissible Tumour
Janine E. Deakin et al.
PLOS GENETICS (2012)
Allorecognition in the Tasmanian Devil (Sarcophilus harrisii), an Endangered Marsupial Species with Limited Genetic Diversity
Alexandre Kreiss et al.
PLOS ONE (2011)
The dominantly expressed class I molecule of the chicken MHC is explained by coevolution with the polymorphic peptide transporter (TAP) genes
Brian A. Walker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation
Gerd Meyer Zu Hoerste et al.
NEUROBIOLOGY OF DISEASE (2010)
The Tasmanian Devil Transcriptome Reveals Schwann Cell Origins of a Clonally Transmissible Cancer
Elizabeth P. Murchison et al.
SCIENCE (2010)
ORIGINS AND EVOLUTION OF A TRANSMISSIBLE CANCER
Clare A. Rebbeck et al.
EVOLUTION (2009)
Interactions of host IL-6 and IFN-γ and cancer-derived TGF-β1 on MHC molecule expression during tumor spontaneous regression
Ya-Wen Hsiao et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Transmission of a fatal clonal tumor by biting occurs due to depleted MHC diversity in a threatened carnivorous marsupial
Hannah V. Siddle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The impact of disease on the survival and population growth rate of the Tasmanian devil
Shelly Lachish et al.
JOURNAL OF ANIMAL ECOLOGY (2007)
Towards a case definition for devil facial tumour disease: What is it?
Stephen B. Pyecroft et al.
ECOHEALTH (2007)
Distribution and impacts of Tasmanian devil facial tumor disease
Hamish McCallum et al.
ECOHEALTH (2007)
The immunohistochemical characterization of devil facial tumor disease (DFTD) in the Tasmanian Devil (Sarcophilus harrisii)
R. Loh et al.
VETERINARY PATHOLOGY (2006)
Clonal origin and evolution of a transmissible cancer
Claudio Murgia et al.
CELL (2006)
Immunology of placentation in eutherian mammals
Ashley Moffett et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Transcriptional regulation of antigen presentation
PJ van den Elsen et al.
CURRENT OPINION IN IMMUNOLOGY (2004)
Tumor-infiltrating lymphocyte secretion of IL-6 antagonizes tumor-derived TGF-β1 and restores the lymphokine-activated killing activity
YW Hsiao et al.
JOURNAL OF IMMUNOLOGY (2004)
Histone modifications in transcriptional regulation
SL Berger
CURRENT OPINION IN GENETICS & DEVELOPMENT (2002)
Presentation of antigens by MHC class II molecules: getting the most out of them
JA Villadangos
MOLECULAR IMMUNOLOGY (2001)
Transcriptional coactivator, CIITA, is an acetyltransferase that bypasses a promoter requirement for TAF(II)250
A Raval et al.
MOLECULAR CELL (2001)
Share Paper
